Free Trial

Algert Global LLC Has $21.27 Million Stake in Itron, Inc. $ITRI

Itron logo with Computer and Technology background

Key Points

  • Algert Global LLC increased its holdings in Itron, Inc. by 12.4% in Q1, owning 203,021 shares valued at approximately $21.27 million, making it the firm's 6th largest holding.
  • Recent research upgrades have included Wall Street Zen raising Itron from a "hold" to a "buy" rating and JPMorgan increasing its price target from $128 to $145, indicating strong analyst confidence.
  • Itron's revenue for the latest quarter was reported at $606.76 million, slightly below the expected $610.36 million, while the company's EPS exceeded consensus at $1.62 compared to $1.33.
  • Need better tools to track Itron? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Algert Global LLC increased its stake in Itron, Inc. (NASDAQ:ITRI - Free Report) by 12.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 203,021 shares of the scientific and technical instruments company's stock after purchasing an additional 22,436 shares during the quarter. Itron makes up 0.5% of Algert Global LLC's investment portfolio, making the stock its 6th largest holding. Algert Global LLC owned about 0.45% of Itron worth $21,268,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of ITRI. GeoWealth Management LLC increased its stake in Itron by 4,580.0% in the 4th quarter. GeoWealth Management LLC now owns 234 shares of the scientific and technical instruments company's stock worth $25,000 after purchasing an additional 229 shares in the last quarter. Wayfinding Financial LLC acquired a new stake in shares of Itron during the first quarter valued at approximately $45,000. CoreCap Advisors LLC lifted its position in shares of Itron by 25.5% in the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock valued at $67,000 after acquiring an additional 125 shares in the last quarter. Contravisory Investment Management Inc. boosted its stake in Itron by 98.0% in the 1st quarter. Contravisory Investment Management Inc. now owns 1,711 shares of the scientific and technical instruments company's stock worth $179,000 after purchasing an additional 847 shares during the period. Finally, Hancock Whitney Corp purchased a new position in Itron during the 4th quarter worth approximately $220,000. Hedge funds and other institutional investors own 96.19% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Guggenheim restated a "buy" rating and issued a $155.00 target price (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Piper Sandler dropped their price target on Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Johnson Rice lowered Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Stephens set a $130.00 target price on Itron in a research note on Monday, August 4th. Finally, Roth Capital increased their price target on shares of Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research report on Tuesday, July 22nd. Eleven research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $136.25.

Get Our Latest Report on Itron

Insider Activity at Itron

In other news, SVP Christopher E. Ware sold 339 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total transaction of $38,968.05. Following the completion of the sale, the senior vice president directly owned 19,468 shares of the company's stock, valued at $2,237,846.60. This trade represents a 1.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Donald L. Reeves III sold 529 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total value of $60,808.55. Following the sale, the senior vice president directly owned 20,151 shares of the company's stock, valued at $2,316,357.45. This trade represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,755 shares of company stock worth $1,879,397. 1.51% of the stock is currently owned by corporate insiders.

Itron Stock Down 0.9%

ITRI traded down $1.15 on Wednesday, reaching $124.69. 423,056 shares of the company traded hands, compared to its average volume of 590,031. The stock's 50 day moving average price is $130.42 and its 200-day moving average price is $114.81. Itron, Inc. has a 52-week low of $90.11 and a 52-week high of $140.04. The company has a market cap of $5.70 billion, a price-to-earnings ratio of 21.31, a PEG ratio of 0.70 and a beta of 1.35. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75.

Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. During the same period last year, the business earned $1.21 EPS. The business's quarterly revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, sell-side analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Itron Company Profile

(Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Articles

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines